Skip to main content

Breadth improved. Advancing trends kept shrinking.

Friday damaged the recovery, but the deeper problem remains the loss of established Stage 2 trends.

Friday, October 30, 20263 min readStage2Stocks Market Desk

S&P 500
-0.6%
on the week
Market
Neutral — Fading
36 sessions in this state
Breadth
52%
above 200-DMA · widened from 50%
Stage 1→2 (wk)
17
net -90 vs 2→3
52w highs / lows
401 / 190
net +211
Stage-2 share
29%
-71 stocks this week

Friday put the breadth recovery under pressure without erasing the week's improvement. The more persistent problem is that recovering participation still is not replenishing established advancing trends. The market remains Neutral — Fading. This week continued the six-week erosion in Stage 2, even as breadth offered evidence that the underlying recovery is still alive.

The recovery has not reached Stage 2

Thursday brought six-week highs in participation above the major moving averages. Friday knocked the share above the 50-day average back to 47.6%, from 52.5%. That is a meaningful setback, but longer-term participation still finished ahead of last week.

Stage 2 tells a less forgiving story. Its share was 44.7% at the start of these six weeks and is now 29.2%. Over the past five sessions, 17 stocks moved from basing into advancing trends, against 107 moving from advancing into topping. The rolling five-session transition balance has stayed negative for 30 sessions. Breadth repair remains real, but it has yet to repair the supply of advancing charts.

Weekly winners are not necessarily trend leaders

Consumer discretionary led the week, with utilities next at a 1.1% gain. Yet only 19.3% of discretionary stocks are in Stage 2, and that share is lower over 20 sessions. The weekly rally has not established broad advancing participation there.

Energy presents the opposite tension. It slipped 0.4% for the week but still leads the one-month and three-month sector returns. Its Stage 2 share held at 56.2% after Thursday's stabilization. That keeps the leadership thread alive, though participation remains down 10.5 percentage points over 20 sessions. The recent steadiness has not reversed that damage.

Communication services was the week's clear setback, falling 9%. Its advancing share is also lower over 20 sessions, so the price weakness has no offsetting participation rebuild.

Technology's rebuild needs a narrower description

My early-week rebuild language for technology was too optimistic. The participation gains are real, but they have not translated into price strength. Technology has 41.6% of its stocks in Stage 2, up 4.4 percentage points over 20 sessions. Its one-month return is still negative.

Semiconductors make that distinction especially clear. Their advancing share is 35.2%, up 13.4 points over 20 sessions, while their one-month return is down 18.7%. Friday's 7.3% decline in the industry further weakens the case for treating that participation improvement as a durable turn. The rebuild remains a live question rather than established leadership.

Narrow pockets still deserve chart review

Financials' erosion did not end this week. Advancing participation stands at 23.9%, down 28.7 percentage points over 20 sessions. Financial data and stock exchanges remain an exception, with 72.7% in Stage 2. That pocket does not repair the sector as a whole.

Thursday's health care interest also survives in a narrower form. Healthcare plans have 60% advancing participation, while Option Care Health and Prime Medicine appear among the week's moves from basing into Stage 2. Those transitions are worth studying, but there are no early setups close to their 50-day averages on tonight's list. New stage entries alone do not establish a timely setup.

The S&P 500 remains above its 200-day average, and 401 stocks finished at fresh annual highs against 190 at new lows. That supports a pullback interpretation rather than a confirmed broad breakdown. For next week's screening, the unresolved test is whether breadth can hold its repair while Stage 2 stops shrinking. Better-looking participation without that second step is still an incomplete recovery.

This week's stage transitions
StockSectorMoveSetup
Prime MedicineHealth Care1→29.2
Option Care HealthHealth Care1→28.4
American Tower Corporation (REIT)Real Estate1→27.4
Warner Music GroupCommunication Services1→26.9
Ulta BeautyConsumer Discretionary1→26.9
GameStopConsumer Discretionary1→26.4
ConcentrixInformation Technology1→26.3
ODDITY TechConsumer Staples1→26.2
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Energy+0.1%+6.5%+9.8%7956%
Consumer Staples+0.1%+5.7%-3.4%5828%
Utilities-0.3%+4.6%-4.8%5511%
Consumer Discretionary-0.4%+5.7%-3.7%5719%
Real Estate-0.7%+1.8%-8.3%5910%
Communication Services-1.4%+1.0%-4.7%5429%
Financials-1.5%+1.1%-2.0%6624%
Industrials-1.8%+0.1%-6.0%6121%
Health Care-2.2%+3.8%+6.2%6638%
Materials-2.4%-4.7%-4.1%6428%
Information Technology-3.6%-4.5%-0.7%6142%
Share of US stocks in Stage 2May 2026 – Oct 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26S&P 500Stocks in Stage 2Latest: 29%
The share of US stocks in Stage 2 over the six months to this wrap, with the S&P 500's shape above it: the market underneath the day's numbers. Source: Stage2Stocks classification of every US stock we cover with enough history, each week.
Try it on Stage2StocksToday's breadth The advance-decline ratio and the share of US stocks above their 200-day average and in Stage 2, day by day.

Work the same data yourself: open the full stock screener, see where money is moving on the sector rotation page, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across US-listed stocks. They are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →